Baseline and procedural characteristics according to sex
| Total (n=10 812) | Men (n=8315) | Women (n=2497) | P value | |
| Age (years), median and IQR | 63.0 (54.0–71.0) | 68.0 (59.0–78.0) | <0.001 | |
| BMI (kg/m2), median and IQR | 28.1 (25.2–31.2) | 27.9 (24.3–32.4) | 0.21 | |
| Diabetes, n (%) | 1586 (19.1%) | 551 (22.1%) | <0.001 | |
| Previous CABG, n (%) | 570 (6.9%) | 129 (5.2%) | 0.003 | |
| Previous PCI, n (%) | 1915 (23.0%) | 466 (18.7%) | <0.001 | |
| CVD, n (%) | 236 (2.8%) | 100 (4.0%) | 0.003 | |
| PVD, n (%) | 263 (3.2%) | 79 (3.2%) | 1.00 | |
| LVEF estimate | ||||
| Normal (>50%) | 3468 (57.3%) | 1127 (62.8%) | <0.001 | |
| Mild dysfunction (45%–50%) | 1589 (26.3%) | 403 (22.5%) | ||
| Moderate dysfunction (35%–44%) | 746 (12.3%) | 200 (11.1%) | ||
| Severe dysfunction (<35%) | 250 (4.1%) | 65 (3.6%) | ||
| eGFR, median (IQR) | 95.6 (73.3–120.6) | 75.9 (54.5–101.7) | <0.001 | |
| ACS type | ||||
| Unstable angina | 1256 (15.1%) | 459 (18.4%) | <0.001 | |
| NSTEMI | 3942 (47.4%) | 1235 (49.5%) | ||
| STEMI | 3117 (37.5%) | 803 (32.2%) | ||
| Cardiac arrest and/or pre-procedure intubation | 388 (4.7%) | 83 (3.3%) | 0.004 | |
| Radial access, n (%) | 4194 (50.5%) | 1027 (41.2%) | <0.001 | |
| Lesion locations | ||||
| Other | 305 (3.7%) | 67 (2.7%) | 0.018 | |
| LAD | 3401 (40.9%) | 1081 (43.3%) | 0.034 | |
| RCA | 2918 (35.1%) | 935 (37.4%) | 0.031 | |
| LCx | 2083 (25.1%) | 511 (20.5%) | <0.001 | |
| Drug-eluting stent | 6366 (76.6%) | 1913 (76.6%) | 0.96 | |
| PCI result successful | 7898 (95.0%) | 2401 (96.2%) | 0.016 |
ACS, acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass grafting; CVD, cerebrovascular disease; LAD, left anterior descending; LCx, left circumflex; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease;RCA, right coronary artery; STEMI, ST-elevation myocardial infarction.